Evidence map›Paper›PMID 26296892›Full record

ArticleThe Journal of biological chemistry2015

Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3).

Evgenia Rouka, Philip C Simister, Melanie Janning, Joerg Kumbrink, Tassos Konstantinou, João R C Muniz, Dhira Joshi, Nicola O'Reilly, Rudolf Volkmer, Brigitte Ritter and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Science advances · 2026
    Article
  2. Review
  3. SHARK-capture identifies functional motifs in intrinsically disordered protein regions.Protein science : a publication of the Protein Society · 2025
    Article
  4. The Alzheimer's Disease Risk Gene CD2AP Functions in Dendritic Spines by Remodeling F-Actin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Genome assemblies forFrontiers in genetics · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Ras and Rab Interactor 3: From Cellular Mechanisms to Human Diseases.Frontiers in cell and developmental biology · 2022
    Review
  13. Synaptic tau: A pathological or physiological phenomenon?Acta neuropathologica communications · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Molecular structure in biomolecular condensates.Current opinion in structural biology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Evgenia RoukaFrom the Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom.
Philip C SimisterFrom the Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom, philip.simister@imm.ox.ac.uk.
Melanie JanningFrom the Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom.
Joerg Kumbrinkthe Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118.
Tassos KonstantinouFrom the Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom.
João R C Munizthe Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Dhira Joshithe Peptide Chemistry Laboratory, London Research Institute Cancer Research UK, London WC2A 3LY, United Kingdom.
Nicola O'Reillythe Peptide Chemistry Laboratory, London Research Institute Cancer Research UK, London WC2A 3LY, United Kingdom.
Rudolf Volkmerthe Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany.
Brigitte Ritterthe Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118.
Stefan Knappthe Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Frank von Delftthe Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom, the Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, United Kingdom, and the Department of Biochemistry, University of Johannesburg, Auckland Park 2006, South Africa.
Kathrin H Kirschthe Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118.
Stephan M FellerFrom the Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford OX3 9DS, United Kingdom, the Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, D-06120 Halle, Germany, stephan.feller@uk-halle.de.
University of Oxford · GBBoston University · USCancer Research UK · GBGenomics (United Kingdom) · GBCharité - Universitätsmedizin Berlin · DEDiamond Light Source · GB

Funding

Lysyl Oxidase Propeptide: Breast Cancer InhibitorR01CA143108 · NCI · TUFTS UNIVERSITY BOSTON · PI SONENSHEIN, GAIL E. · 2010 to 2014
$2.5M
Medical Research CouncilNCI NIH HHS CA143108NCI NIH HHS R01 CA143108Wellcome Trust 106169
6 · The paper itself

Abstract

CD2AP is an adaptor protein involved in membrane trafficking, with essential roles in maintaining podocyte function within the kidney glomerulus. CD2AP contains three Src homology 3 (SH3) domains that mediate multiple protein-protein interactions. However, a detailed comparison of the molecular binding preferences of each SH3 remained unexplored, as well as the discovery of novel interactors. Thus, we studied the binding properties of each SH3 domain to the known interactor Casitas B-lineage lymphoma protein (c-CBL), conducted a peptide array screen based on the recognition motif PxPxPR and identified 40 known or novel candidate binding proteins, such as RIN3, a RAB5-activating guanine nucleotide exchange factor. CD2AP SH3 domains 1 and 2 generally bound with similar characteristics and specificities, whereas the SH3-3 domain bound more weakly to most peptide ligands tested yet recognized an unusually extended sequence in ALG-2-interacting protein X (ALIX). RIN3 peptide scanning arrays revealed two CD2AP binding sites, recognized by all three SH3 domains, but SH3-3 appeared non-functional in precipitation experiments. RIN3 recruited CD2AP to RAB5a-positive early endosomes via these interaction sites. Permutation arrays and isothermal titration calorimetry data showed that the preferred binding motif is Px(P/A)xPR. Two high-resolution crystal structures (1.65 and 1.11 Å) of CD2AP SH3-1 and SH3-2 solved in complex with RIN3 epitopes 1 and 2, respectively, indicated that another extended motif is relevant in epitope 2. In conclusion, we have discovered novel interaction candidates for CD2AP and characterized subtle yet significant differences in the recognition preferences of its three SH3 domains for c-CBL, ALIX, and RIN3.

Indexed as

src Homology DomainsAdaptor Proteins, Signal TransducingAmino Acid SequenceBinding SitesCarrier ProteinsComputational BiologyCrystallography, X-RayCytoskeletal ProteinsGuanine Nucleotide Exchange FactorsHEK293 CellsHumansMolecular Sequence Dataras ProteinsSequence Homology, Amino AcidAdaptor Proteins, Signal TransducingCarrier ProteinsCD2-associated proteinCytoskeletal ProteinsGuanine Nucleotide Exchange Factorsras ProteinsRIN3 protein, humanAlzheimer diseasebreast cancerCD2AP (CD2-associated protein)domain plasticityfocal segmental glomerulosclerosis (FSGS)nephrologypolyproline type II (PP-II) helixRIN3 (Ras and Rab interactor 3)T-cell biologyx-ray crystallography

Identifiers

PMID26296892
PMCPMC4646179
OpenAlexW1945717549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.